You will have heard of the “antibiotic apocalypse” – the nightmare scenario in which we run out of treatments for bacterial infections because too many bacteria have acquired antibiotic

resistance. It has been the subject of a major documentary and endless books and articles. David Cameron, when prime minister of the UK, commissioned a major review on the subject, led by

the distinguished economist Lord Jim O'Neill. England’s chief medical officer, Dame Sally Davies, warned that the apocalypse may already be upon us. I discussed it at the Edinburgh

Fringe recently as part of the Cabaret of Dangerous Ideas. Being able to diagnose bacterial infections more quickly is seen as a key to the problem, as highlighted in the ten-point plan in

bacteria that results in them developing resistance. This would help our already limited range of antibiotics remain effective for longer. To incentivise the research community, the UK

government set up the £10m Longitude Prize a couple of years ago. So how are we getting on? DIAGNOSING _SALMONELLA_ To give a sense of the challenge, take _Salmonella_. This bacteria can

frequently cause gastroenteritis (food poisoning) from people eating contaminated meat, eggs and chicken, among other things. In some countries, different types of _Salmonella_ can cause

more serious infections such as Typhoid fever. This can be life-threatening to the elderly, newborns and those with defective immune systems – another reason why rapid diagnosis is

important. In the UK, clinical laboratories identify bacteria that cause infections according to the Standards for Microbiology Investigations (SMI). For _Salmonella_, the standard practice

is to do four tests. You start by growing a bacterial culture from a sample of blood or another bodily product in a petri dish – this scales up the bacteria and makes it easier to identify.

Next the technician has to first analyse the bacterial cells under a microscope; then mix _Salmonella_-specific antibodies with a blood sample to look for signs of clumps forming

(agglutination); then carry out biochemical tests that identify bacteria by revealing what kind of enzymes they possess. Before any of this can begin, a patient needs to present at the

clinic or hospital and provide a suitable sample. This may be a number of hours after the onset of infection. Growing a culture can take at least 24 hours. The microscope study and the

agglutination only take minutes, but the enzyme testing will take another 24 hours. Sometimes another prior step is necessary to make the bacteria easier to identify. In a blood sample, for

example, bacteria might be present in low numbers which can affect test sensitivity. Or where it’s a faecal sample, there will be other bacteria present which could affect the sensitivity of

any tests done. This extra step can involve various ways of enriching the bacteria – for instance subjecting the sample to conditions that will favour the bacteria in question to the

detriment of others. This will normally add another 24 hours. Put everything together and you’re talking about between two and five days from infection to diagnosis. Other more rapid tests

that have become possible in recent years. Nucleic acid amplification tests (NAATs) can identify bacteria based on the presence of their specific DNA within hours; and MALDI-TOF mass

spectometry can identify bacteria in minutes from the protein components of their cells. Yet these require specialist equipment that is too expensive for many laboratories. Both still

require a cultured sample, which again adds 24 hours. And NAATs in particular have limitations which can produce false results and inaccuracies. THE WAY FORWARD So where do we go from here?

The Holy Grail is something analogous to a pregnancy test in terms of simplicity and speed. Such a test could be administered by a doctor or nurse at the point of first consultation and

provide a diagnosis before your appointment is finished. There is precedent for rapid disease diagnosis with the release of a self-test for HIV, where you can obtain a result in about 15

minutes. Producing an equivalent test for bacterial infection is more complex, however. Where the HIV self-test works by detecting HIV antibodies, with bacterial infection it can take time

for antibodies to be produced while the onset of symptoms can be rapid. Some bacteria are also covered in molecules which can fool the immune system so that no antibodies are produced.

Another hurdle that would need to be overcome is that any test would need to be able to distinguish the bacteria causing the infection from the harmless bacteria we normally find in the

body. In short, the development of a new rapid method of diagnostics is by no means an easy task. I think it unlikely that either MALDI-TOF mass spectrometry or NAATs are the answer. In my

laboratory we are trying to use our knowledge of bacterial physiology to think beyond these methods to design microbial sensors that can detect the harmful bacteria, but without the need for

culture. I am aware that others are exploring developing a diagnostic that can sense whether an infection is present by identifying specific molecules produced by the body in response to

infection. Either way, I am optimistic that we will find a solution within the next five to ten years, and that it will come from a multidisciplinary approach from scientists, engineers and

industry working in partnership. With £10m Longitude Prize on offer too, it’s a great incentive. For most working towards this, however, the real reward will be contributing to averting one

of the most serious threats that humanity currently faces.